SLC22A8 and diabetes mellitus: Moreover, the targets of our findings have some overlap with those in existing network analysis on actual patients with DM with HF, that is ALB, FDFT1, SLC22A8, ABCG2, MME, LGALS3 and FUCA1, which act as biomarkers in HF patients with DM [26, 27].